The effect of normal red cell constituents on the activities of red cell enzymes.
D000429:Alcohol Oxidoreductases / Q000032:analysis / Q000097:blood*; D000447:Aldehydes / Q000494:pharmacology; D001639:Bicarbonates / Q000494:pharmacology; D003404:Creatinine / Q000494:pharmacology; D004912:Erythrocytes / Q000187:drug effects / Q000201:enzymology*; D005634:Fructose-Bisphosphate Aldolase / Q000037:antagonists & inhibitors; D005956:Glucose-6-Phosphate Isomerase / Q000037:antagonists & inhibitors; D005954:Glucosephosphate Dehydrogenase / Q000037:antagonists & inhibitors; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases / Q000037:antagonists & inhibitors; D005994:Glycerophosphates / Q000494:pharmacology*; D006593:Hexokinase / Q000037:antagonists & inhibitors; D007700:Kinetics; D010732:Phosphofructokinase-1 / Q000037:antagonists & inhibitors; D010733:Phosphoglucomutase / Q000037:antagonists & inhibitors; D010734:Phosphogluconate Dehydrogenase / Q000037:antagonists & inhibitors; D010770:Phosphotransferases / Q000032:analysis / Q000097:blood*; D010847:Picolines / Q000494:pharmacology; D011732:Pyridoxal Phosphate / Q000494:pharmacology*; D011736:Pyridoxine / Q000494:pharmacology; D011770:Pyruvate Kinase / Q000037:antagonists & inhibitors
D000447:Aldehydes; D001639:Bicarbonates; D005994:Glycerophosphates; D010847:Picolines; D011732:Pyridoxal Phosphate; D003404:Creatinine; D000429:Alcohol Oxidoreductases; D010734:Phosphogluconate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases; D010770:Phosphotransferases; D006593:Hexokinase; D010732:Phosphofructokinase-1; D011770:Pyruvate Kinase; D005634:Fructose-Bisphosphate Aldolase; D005956:Glucose-6-Phosphate Isomerase; D010733:Phosphoglucomutase; D011736:Pyridoxine